2023
Patient perceptions of altering chemotherapy treatment due to peripheral neuropathy
Hertz D, Tofthagen C, Rossi E, Bernasconi D, Lim J, Carlson M, Sheffield K, Nekhlyudov L, Grech L, Von Ah D, Mayo S, Ruddy K, Chan A, Alberti P, Lustberg M, Tanay M. Patient perceptions of altering chemotherapy treatment due to peripheral neuropathy. Supportive Care In Cancer 2023, 32: 48. PMID: 38129602, DOI: 10.1007/s00520-023-08209-0.Peer-Reviewed Original ResearchConceptsChemotherapy-induced peripheral neuropathyNeurotoxic chemotherapy treatmentChemotherapy treatmentSymptom resolutionPeripheral neuropathySevere chemotherapy-induced peripheral neuropathyCommon reason participantsMethodsA cross-sectional online surveyBetter patient educationCross-sectional online surveyNeurotoxic chemotherapyCIPN symptomsMedian ageMost patientsTreating clinicianLong-term benefitsPatients' perceptionsPatient educationPractice guidelinesTreatment goalsClinicians' understandingTreatment efficacyConclusionsThis surveyPatientsSymptoms
2020
Current status of integrating oncology and palliative care in Japan: a nationwide survey
Uneno Y, Sato K, Morita T, Nishimura M, Ito S, Mori M, Shimizu C, Horie Y, Hirakawa M, Nakajima T, Tsuneto S, Muto M. Current status of integrating oncology and palliative care in Japan: a nationwide survey. BMC Palliative Care 2020, 19: 12. PMID: 31980015, PMCID: PMC6982384, DOI: 10.1186/s12904-020-0515-5.Peer-Reviewed Original ResearchConceptsPalliative careExecutive physiciansGovernment-designated cancer hospitalsIOP indicatorsCross-sectional nationwide surveyCancer Control ActRoutine symptom screeningNationwide surveyBackgroundPalliative carePC staffPC servicesOncology careMethodsThe questionnairePhysicians' perceptionsSymptom screeningPC resourcesStaff membersCareConclusionsThis surveyCancer HospitalEarly referralDaily practiceResultsIn totalHospitalOncology
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply